Analysts: Legg Mason Investment Performance Remains Weak and 3 More Research Notes to Investigate
Legg Mason (NYSE:LM): Goldman expects incremental weakness for Legg Mason flows following additional industry-wide bond fund outflows and fixed income AuM pressures, and adds that relative investment performance remains weak and trends will remain soft in the near-term. Goldman keeps a Sell rating on the shares.
WuXi PharmaTech (NYSE:WX): Oppenheimer finds WuXi’s valuation very compelling, and after meeting with WuXi ‘s CFO, Oppenheimer believes that the company can beat its 2013 guidance. The firm is also upbeat about the company’s longer term outlook and keeps an Outperform rating on the shares.
GNC Holdings (NYSE:GNC): Wells Fargo is more confident in the company’s outlook after meeting with management, and believes that its sector has positive growth trends. The firm is also upbeat about the company’s new member pricing and marketing programs, and it keeps an Outperform rating on the stock.
Kinross Gold (NYSE:KGC): Kinross has been downgraded from Buy to Neutral at UBS, following a reduction in its gold price forecast. The firm has also lowered its price target to $5.50, from $8.
Don’t Miss: SoftBank: Sprint Acquisition to Close by July.